Skip to main content
Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
155.17
-0.33 (-0.21%)
Nov 22, 2024, 4:00 PM EST - Market closed

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $22.47B in the quarter ending September 29, 2024, with 5.25% growth. This brings the company's revenue in the last twelve months to $87.70B, up 4.77% year-over-year. In the year 2023, Johnson & Johnson had annual revenue of $85.16B with 6.46% growth.

Revenue (ttm)
$87.70B
Revenue Growth
+4.77%
P/S Ratio
4.26
Revenue / Employee
$664,867
Employees
131,900
Market Cap
373.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jan 1, 2017 Pro Pro Pro
Jan 3, 2016 Pro Pro Pro
Dec 28, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 393.90B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher 42.37B
Abbott Laboratories 41.22B
Eli Lilly 40.86B
Revenue Rankings

JNJ News

More News